What does ASKA Pharmaceutical Holdings do with its cash?

Cash conversion (operating CF ÷ operating income)

108.0%

Cash vs. profit gap

¥879M（純利益の 16.2%）

Shareholder payments — dividends

of net income 29.8% · of FCF 47.2%

CapEx intensity (capex ÷ revenue)

4.0%

Investing CF relative to operating CF

91.3%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

• Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
• Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
• Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.